SCHY - ETF AI Analysis
Top Page
Schwab International Dividend Equity ETF (SCHY)
SCHY, the Schwab International Dividend Equity ETF, earns a solid overall rating thanks to several strong, diversified holdings like TotalEnergies, DHL Group, GlaxoSmithKline, and Vinci, which combine solid financial performance, attractive valuations, and healthy dividends. Some holdings such as Wesfarmers and Unilever show weaker technical trends or potential overvaluation, which slightly weigh on the fund’s appeal. The main risk factor is its concentration in a set of large international dividend payers, where overbought technical conditions or sector-specific challenges could impact short-term performance.
SCHY vs. SPDR S&P 500 ETF (SPY)
- AUM
- 2.67B
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.08%
- Beta
- 0.36
- Issuer
- Schwab
- Inception Date
- Apr 29, 2021
- Dividend Yield
- 3.56%
- Asset Class
- Equity
- Index Tracked
- Dow Jones International Dividend 100 Index
SCHY Summary
SCHY is the Schwab International Dividend Equity ETF, which follows the Dow Jones International Dividend 100 Index. It invests in large and mid-sized companies outside the U.S. that pay relatively high dividends. The fund holds well-known names like Unilever and Roche, along with many other firms across Europe, Asia, and beyond. Investors might consider SCHY if they want steady income from dividends plus diversification away from only U.S. stocks. A key risk is that international stock prices and currencies can go up and down, so the value of the ETF and its income are not guaranteed.
How much will it cost me?
This ETF has an expense ratio of 0.08%, which means you’ll pay about $0.80 per year for every $1,000 you invest. That’s lower than the average ETF because it’s passively managed and tracks an index instead of paying a team to actively pick stocks.
What would affect this ETF?
SCHY could benefit if international economies outside the U.S. stay stable or grow, supporting steady dividends from its defensive, healthcare, and consumer-focused holdings like Roche, Unilever, and GSK, and if global interest rates eventually ease, making dividend income more attractive. On the downside, weaker growth or political issues in foreign markets, stricter regulations on tobacco, energy, or utilities, or higher interest rates that draw investors toward safer income options could pressure both dividends and share prices in this ETF.
SCHY Top 10 Holdings
SCHY leans heavily on European dividend stalwarts, with energy names like TotalEnergies and ENI doing the heavy lifting as they’ve been steadily rising and powering recent returns. DHL has also been a quiet engine of growth, adding some industrial strength to the mix. On the flip side, consumer giants Unilever and Wesfarmers have been losing steam, while utilities player Enel and infrastructure group Vinci are lagging, acting as mild brakes on performance. Overall, the fund is globally diversified outside the U.S., but notably anchored in Europe and in classic income sectors like energy, consumer defensive, and health care.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | ― | ― | ― | ― | 73Outperform | |
| British American Tobacco | 4.21% | $112.19M | GBP 94.31B | 17.57% | 71Outperform | |
| ENI S.p.A. | 4.29% | $114.28M | EUR 75.88B | 72.75% | 63Neutral | |
| DHL Group | 4.08% | $108.73M | EUR 64.56B | 44.72% | 76Outperform | |
| Unilever | 3.99% | $106.37M | GBP 103.84B | -4.95% | 72Outperform | |
| Wesfarmers Limited | 4.05% | $108.03M | AUD 90.35B | -15.00% | 68Neutral | |
| GlaxoSmithKline | 3.97% | $105.78M | GBP 74.85B | 15.82% | 77Outperform | |
| Enel S.p.A. | 3.95% | $105.37M | EUR 91.19B | 8.44% | 67Neutral | |
| TotalEnergies SE | 3.99% | $106.52M | EUR 178.44B | 50.82% | 78Outperform | |
| Vinci SA | ― | ― | ― | ― | 76Outperform |
SCHY Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHY, the sentiment is Positive. The current price of 33.03 is above the 20-day moving average (MA) of 31.98, above the 50-day MA of 32.42, and above the 200-day MA of 31.75, indicating a bullish trend. The MACD of 0.17 indicates Negative momentum. The RSI at 65.60 is Neutral, neither overbought nor oversold. The STOCH value of 95.26 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCHY.
SCHY Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $33.03 | $35.00(5.96% Upside) | $2.67B | 0.08% | 62Neutral | |
| $42.32 | $48.61(14.87% Upside) | $8.32B | 0.50% | 59Neutral | |
| $53.34 | $54.14(1.49% Upside) | $8.07B | 0.43% | 71Outperform | |
| $47.06 | ― | $516.19M | 0.45% | 57Neutral | |
| $33.96 | ― | $202.60M | 0.75% | 65Neutral | |
| $34.98 | $40.52(15.84% Upside) | $16.00M | 0.39% | 62Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SCHY | Schwab International Dividend Equity ETF | 33.03 | 5.63 | 20.56% | |
| IDV | iShares International Select Dividend ETF | 42.32 | 7.14 | 20.29% | |
| FDL | First Trust Morningstar Dividend Leaders Index Fund | 53.34 | 11.78 | 28.36% | |
| DWX | SPDR S&P International Dividend ETF | 47.06 | 5.40 | 12.96% | |
| IDVZ | Opal International Dividend Income ETF | 33.96 | 4.25 | 14.32% | |
| VDI | Virtus International Dividend ETF | 34.98 | 5.48 | 18.56% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.